Publication | Open Access

Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Surgical OncologyPatient-reported OutcomesBreast OncologyMedicineAnastrozole Versus TamoxifenBreast CancerSurgeryPharmacotherapyNsabp B-35Cancer TreatmentOncologyRadiation Oncology